Rapid resolution of erythrodermic atopic dermatitis with upadacitinib: A case report.
SAGE Open Med Case Rep
; 12: 2050313X241260497, 2024.
Article
em En
| MEDLINE
| ID: mdl-38881978
ABSTRACT
Atopic dermatitis is a chronic inflammatory skin disease that may progress to erythroderma in severe cases. Biologic agents such as dupilumab have recently become the mainstay of systemic treatment for moderate-to-severe cases, yet many patients remain refractory to therapy. Here, we present a case of erythrodermic atopic dermatitis, resistant to prednisone and dupilumab, with remarkably rapid achievement of remission following treatment with upadacitinib, an oral selective Janus kinase 1 inhibitor.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
SAGE Open Med Case Rep
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Canadá